Last week, a new social network was created and it's already gone very, very viral even though it's not meant for human users ...
THE Ethics and Anti-Corruption Commission (EACC) recently released a 2024 report on corruption in Kenya. For economists, the report continues to demonstrate that corruption is a significant, ...
In the latest CDP evaluation, APP Group has maintained its B score across all categories: climate change, forests, and water security. This score indicates that APP is implementing recognised best ...
The debate over whether to adopt AI has already closed in most British boardrooms. Investment is now a non‑negotiable. PwC’s ...
Vietnam Investment Review on MSN
SCAI Endorses CathWorks FFRangio Technology
NEWPORT BEACH, Calif., Feb. 4, 2026 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced that the Society for Cardiovascular Angiography & Interventions (SCAI) published ...
PREMIUM TIMES gathered that the hoodlums broke some windows at the secretariat and damaged other property at the building ...
allAfrica.com on MSN
Explainer - Why Nature Is Everyone's Business
Our food, fuel, and fortunes come from nature, but as these resources are turned into profits, the balance between exploiting and replenishing the planet is ever more precarious.Global businesses ...
Expanding international trade and increasing exposure to natural disasters have elevated the need for robust cargo coverage, protecting businesses from losses caused by extreme weather events, ...
Invoca recently announced new integrations with Reddit Ads and LinkedIn Ads, allowing marketers to connect social ad performance with leads, conversions, and revenue across contact centers and ...
Complaints to the health regulator from a disgruntled ex-employee who tried to sell tarot card readings to her patients have destroyed Jenna’s mental health and cost thousands in legal fees and higher ...
Exelixis, Inc. (Nasdaq: EXEL) today announced that its New Drug Application (NDA) for zanzalintinib, in combination with atezolizumab (Tecentriq®), has been accepted for review in the U.S. for the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果